KHK2455
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Glioblastoma Multiforme
Conditions
Glioblastoma Multiforme
Trial Timeline
— → —
NCT ID
NCT04321694About KHK2455
KHK2455 is a pre-clinical stage product being developed by Kyowa Kirin for Glioblastoma Multiforme. The current trial status is completed. This product is registered under clinical trial identifier NCT04321694. Target conditions include Glioblastoma Multiforme.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04321694 | Pre-clinical | Completed |
Competing Products
20 competing products in Glioblastoma Multiforme